GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (STU:GBE) » Definitions » Total Equity

Genus (STU:GBE) Total Equity : €665.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genus Total Equity?

Genus's total equity for the quarter that ended in Dec. 2023 was €665.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Genus Total Equity Historical Data

The historical data trend for Genus's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Total Equity Chart

Genus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 537.28 549.58 578.09 666.51 661.02

Genus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 595.96 666.51 655.28 661.02 665.00

Genus Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Genus's Total Equity for the fiscal year that ended in Jun. 2023 is calculated as

Total Equity=Total Assets(Q: Jun. 2023 )-Total Liabilities(Q: Jun. 2023 )
=1174.145-513.127
=661.0

Genus's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1223.324-558.325
=665.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Total Equity Related Terms

Thank you for viewing the detailed overview of Genus's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (STU:GBE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (STU:GBE) » Definitions » Total Equity
Comparable Companies
LSE:ONT LSE:PRTC LSE:BVXP LSE:OXB LSE:HVO LSE:AVCT LSE:4BB LSE:FUM LSE:FARN LSE:SCLP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
GENSF:USA GNSl:UK GNS:UK GBE:Germany
Address
Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ
Website
https://www.genusplc.com
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (STU:GBE) Headlines

No Headlines